{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:36:07Z","timestamp":1794558967023,"version":"4.9.1"},"reference-count":320,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK133694"],"award-info":[{"award-number":["R01DK133694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30DK132710"],"award-info":[{"award-number":["5P30DK132710"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA020744"],"award-info":[{"award-number":["R01AA020744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA017729"],"award-info":[{"award-number":["R01AA017729"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA032418"],"award-info":[{"award-number":["R01AA032418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AAA011576"],"award-info":[{"award-number":["R01AAA011576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PAIR ob\\u00E9sit\\u00E9 INCA\/Inca_18713"],"award-info":[{"award-number":["PAIR ob\\u00E9sit\\u00E9 INCA\/Inca_18713"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Equipe FRM: EQU201903007824"],"award-info":[{"award-number":["Equipe FRM: EQU201903007824"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1382, Project-ID 403224013"],"award-info":[{"award-number":["SFB1382, Project-ID 403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB\/TR 412, Project-ID 535081457"],"award-info":[{"award-number":["SFB\/TR 412, Project-ID 535081457"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PMTargets\/0002\/2024"],"award-info":[{"award-number":["PMTargets\/0002\/2024"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/04138\/2025"],"award-info":[{"award-number":["UID\/04138\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["Project ID: 70116308"],"award-info":[{"award-number":["Project ID: 70116308"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-198065"],"award-info":[{"award-number":["PJT-198065"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-175155"],"award-info":[{"award-number":["PJT-175155"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-AAPG2022-CE14-DNAFAT"],"award-info":[{"award-number":["ANR-AAPG2022-CE14-DNAFAT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["Equipe Labellis\\u00E9e LIGUE 2023"],"award-info":[{"award-number":["Equipe Labellis\\u00E9e LIGUE 2023"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004907","name":"IHI","doi-asserted-by":"publisher","award":["101136259"],"award-info":[{"award-number":["101136259"]}],"id":[{"id":"10.13039\/501100004907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004907","name":"IHI","doi-asserted-by":"publisher","award":["101136622"],"award-info":[{"award-number":["101136622"]}],"id":[{"id":"10.13039\/501100004907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004907","name":"IHI","doi-asserted-by":"publisher","award":["101132901"],"award-info":[{"award-number":["101132901"]}],"id":[{"id":"10.13039\/501100004907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004907","name":"IHI","doi-asserted-by":"publisher","award":["777377"],"award-info":[{"award-number":["777377"]}],"id":[{"id":"10.13039\/501100004907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K0019494\/1"],"award-info":[{"award-number":["MR\/K0019494\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R023026\/1"],"award-info":[{"award-number":["MR\/R023026\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["UKRI526"],"award-info":[{"award-number":["UKRI526"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["PGL22\/100014"],"award-info":[{"award-number":["PGL22\/100014"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhep.2026.04.029","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:06:15Z","timestamp":1779840375000},"page":"345-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["EASL position paper on preclinical models of steatotic liver disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Suchira","family":"Gallage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui E.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Estall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina G.","family":"Tiniakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Desdouets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.04.029_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"\u039cetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2024.11.025","article-title":"Towards more consistent models and consensual terminology in preclinical research for steatotic liver disease","volume":"82","author":"Meijnikman","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101499","article-title":"Alcohol-related liver disease: A global perspective","volume":"29","author":"Narro","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib7","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/j.jhep.2025.05.012","article-title":"Is MetALD an all-inclusive term for liver disease caused by alcohol and metabolic dysfunction?","volume":"83","author":"Baffy","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib8","article-title":"Introducing 'ALD-Met': Bridging the Gap Between 'MetALD' and 'ALD' for Heavy Drinkers With Metabolic Dysfunction","volume":"15","author":"Kumar","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.32315","article-title":"Placebo effect on progression and regression in NASH: Evidence from a meta-analysis","volume":"75","author":"Ng","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib14","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/j.cgh.2021.05.059","article-title":"The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply Explained","volume":"20","author":"Rowe","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib15","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Raverdy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib16","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Jamialahmadi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh9940","article-title":"Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population","volume":"16","author":"Ding","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2024.01.002","article-title":"Organoid-guided precision hepatology for metabolic liver disease","volume":"80","author":"Osonoi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100279","article-title":"Engineering liver disease models in vitro: emerging trends and innovations","volume":"3","author":"Rao","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001417","article-title":"Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib25","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","article-title":"Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver","volume":"79","author":"Newsome","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib26","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib29","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"Bmj"},{"key":"10.1016\/j.jhep.2026.04.029_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083735","article-title":"Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial","volume":"389","author":"Lin","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.jhep.2026.04.029_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","article-title":"FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond","volume":"81","author":"Harrison","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib34","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2502242","article-title":"Efruxifermin in Compensated Liver Cirrhosis Caused by MASH","volume":"392","author":"Noureddin","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jhep.2026.04.029_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jhep.2023.07.004","article-title":"Treating NASH by targeting peroxisome proliferator-activated receptors","volume":"79","author":"Staels","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib37","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","volume":"79","author":"Adorini","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib38","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2026.04.029_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.10.042","article-title":"Pharmacologic inhibition of lipogenesis for the treatment of NAFLD","volume":"80","author":"Esler","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/HEP.0000000000000439","article-title":"Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study","volume":"78","author":"Anstee","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib43","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jhep.2025.06.007","article-title":"Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases","volume":"83","author":"Jaeckel","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx0368","article-title":"Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis","volume":"18","author":"Yashaswini","year":"2026","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41575-025-01068-6","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2024.12.046","article-title":"AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials","volume":"83","author":"Armisen","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-025-01162-9","article-title":"Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models","author":"Leslie","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm.4346","article-title":"Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling","volume":"23","author":"Giles","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib49","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2026.04.029_bib51","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cell.2012.04.037","article-title":"Gut immune maturation depends on colonization with a host-specific microbiota","volume":"149","author":"Chung","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib52","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/nbt.3353","article-title":"A catalog of the mouse gut metagenome","volume":"33","author":"Xiao","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2026.04.029_bib53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2221485","article-title":"Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2026.04.029_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s12276-020-0473-2","article-title":"Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics","volume":"52","author":"Park","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.029_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2021.12.003","article-title":"The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping","volume":"30","author":"Beresford-Jones","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2026.04.029_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062578","article-title":"Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome","volume":"8","author":"Krych","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41467-019-13836-5","article-title":"The Mouse Gut Microbial Biobank expands the coverage of cultured bacteria","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib60","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1038\/s41467-025-60554-2","article-title":"Laboratory mice engrafted with natural gut microbiota possess a wildling-like phenotype","volume":"16","author":"Runge","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s42255-021-00439-y","article-title":"Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity","volume":"3","author":"Hild","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib62","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jcmgh.2021.05.010","article-title":"Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet","volume":"12","author":"Ganguly","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib64","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jhep.2026.04.029_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.jhep.2026.04.029_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2026.04.029_bib68","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib69","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1530-0277.2011.01472.x","article-title":"A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis","volume":"35","author":"G\u00e4bele","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2026.04.029_bib70","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The Role of Cholesterol in the Pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib72","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molmet.2017.10.009","article-title":"Optimal housing temperatures for mice to mimic the thermal environment of humans: An experimental study","volume":"7","author":"Fischer","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.molmet.2019.04.001","article-title":"What is the best housing temperature to translate mouse experiments to humans?","volume":"25","author":"Keijer","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib75","article-title":"Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota","volume":"2","author":"Ahmed","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1095132","article-title":"Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease","volume":"14","author":"Oates","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.029_bib77","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00124.2023","article-title":"Thermoneutral housing does not accelerate metabolic dysfunction-associated fatty liver disease in male or female C57Bl\/6J mice fed a Western diet","volume":"325","author":"Nunes","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib78","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221738","article-title":"The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression","volume":"220","author":"Benegiamo","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05607","article-title":"The genetic architecture of NAFLD among inbred strains of mice","volume":"4","author":"Hui","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jhep.2026.04.029_bib80","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.30113","article-title":"The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice","volume":"68","author":"Hui","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib81","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1538\/expanim.19-0148","article-title":"High fat diet induced obesity model using four strainsof mice: Kunming, C57BL\/6, BALB\/c and ICR","volume":"69","author":"Li","year":"2020","journal-title":"Exp Anim"},{"key":"10.1016\/j.jhep.2026.04.029_bib82","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db12-1054","article-title":"Identification of a loss-of-function mutation in Ube2l6 associated with obesity resistance","volume":"62","author":"Marcelin","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2026.04.029_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/db15-0982","article-title":"Attention to Background Strain Is Essential for Metabolic Research: C57BL\/6 and the International Knockout Mouse Consortium","volume":"65","author":"Fontaine","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2026.04.029_bib84","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molmet.2014.09.006","article-title":"Defective insulin secretory response to intravenous glucose in C57Bl\/6J compared to C57Bl\/6N mice","volume":"3","author":"Fergusson","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jcmgh.2021.11.012","article-title":"Spontaneous Cholemia in C57BL\/6 Mice Predisposes to Liver Cancer in NASH","volume":"13","author":"Gallage","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1242\/dmm.024547","article-title":"Using the mouse to model human disease: increasing validity and reproducibility","volume":"9","author":"Justice","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhep.2026.04.029_bib87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2202-14-37","article-title":"Improving basic and translational science by accounting for litter-to-litter variation in animal models","volume":"14","author":"Lazic","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jhep.2026.04.029_bib88","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jhep.2026.04.029_bib89","article-title":"A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib90","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000523","article-title":"Sex- and age-associated factors drive the pathophysiology of MASLD","volume":"8","author":"Yadav","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107795","article-title":"Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL\/6J mice","volume":"35","author":"Casimiro","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jhep.2026.04.029_bib92","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/oby.20811","article-title":"Variations in body weight, food intake and body composition after long-term high-fat diet feeding in C57BL\/6J mice","volume":"22","author":"Yang","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhep.2026.04.029_bib93","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00321.2020","article-title":"Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease","volume":"319","author":"Zhang","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib94","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.molmed.2024.05.013","article-title":"Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Cherubini","year":"2024","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib95","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2025.08.007","article-title":"Sex-related variations in liver homeostasis and disease: From zonation dynamics to clinical implications","volume":"84","author":"Matz-Soja","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib97","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41467-025-58560-5","article-title":"The Sex Inclusive Research Framework to address sex bias in preclinical research proposals","volume":"16","author":"Karp","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13915","article-title":"The role of the circadian clock in the development, progression, and treatment of non-alcoholic fatty liver disease","volume":"237","author":"de Assis","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jhep.2026.04.029_bib99","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2017.04.015","article-title":"Diurnal Oscillations in Liver Mass and Cell Size Accompany Ribosome Assembly Cycles","volume":"169","author":"Sinturel","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.jhep.2026.04.029_bib100","article-title":"Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jhep.2026.04.029_bib101","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib102","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.006239","article-title":"Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice","volume":"3","author":"Ayala","year":"2010","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhep.2026.04.029_bib103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41684-024-01473-5","article-title":"Revisited guidelines for metabolic tolerance tests in mice","volume":"54","author":"Moro","year":"2025","journal-title":"Lab Anim (NY)."},{"key":"10.1016\/j.jhep.2026.04.029_bib104","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s42255-021-00414-7","article-title":"GTTs and ITTs in mice: simple tests, complex answers","volume":"3","author":"Virtue","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tem.2024.03.005","article-title":"Is MASLD lost in translation in mice?","volume":"35","author":"Gunes","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib107","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1172\/JCI112981","article-title":"Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats","volume":"79","author":"Rossetti","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.04.029_bib108","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm1196-1254","article-title":"Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene","volume":"2","author":"Scrocchi","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.029_bib110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbrc.2015.02.024","article-title":"Compensatory hyperinsulinemia in high-fat diet-induced obese mice is associated with enhanced insulin translation in islets","volume":"458","author":"Kanno","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib111","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1242\/dmm.003467","article-title":"Mouse models of the metabolic syndrome","volume":"3","author":"Kennedy","year":"2010","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhep.2026.04.029_bib112","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1073\/pnas.0608703104","article-title":"Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance","volume":"104","author":"Okada","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jhep.2026.04.029_bib113","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science."},{"key":"10.1016\/j.jhep.2026.04.029_bib114","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1096-4959(03)00046-0","article-title":"Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats","volume":"135","author":"Hogarth","year":"2003","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib116","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.029_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33419-6","article-title":"Association between body mass index and fatty liver risk: A dose-response analysis","volume":"8","author":"Fan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib118","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.31897","article-title":"A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD","volume":"74","author":"Im","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib119","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cmet.2021.09.004","article-title":"Sweet death\": Fructose as a metabolic toxin that targets the gut-liver axis","volume":"33","author":"Febbraio","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose stimulated de novo lipogenesis is promoted by inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071805","article-title":"Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol","volume":"10","author":"Eng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2026.04.029_bib122","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fphys.2019.00770","article-title":"The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)","volume":"10","author":"Drescher","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhep.2026.04.029_bib123","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib124","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2026.04.029_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50328-5","article-title":"Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis","volume":"13","author":"Hansen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib126","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/cts.13235","article-title":"Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH","volume":"15","author":"M\u00f8llerh\u00f8j","year":"2022","journal-title":"Clin Transl Sci."},{"key":"10.1016\/j.jhep.2026.04.029_bib127","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/HEP.0000000000000933","article-title":"Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation","volume":"81","author":"Moore","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib129","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s42255-025-01355-1","article-title":"A non-apoptotic caspase-8-meteorin pathway in hepatocytes promotes MASH fibrosis","volume":"7","author":"Wang","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib130","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1038\/s41467-018-06931-6","article-title":"Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/iep.12240","article-title":"Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet","volume":"98","author":"Ikawa-Yoshida","year":"2017","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jhep.2026.04.029_bib132","doi-asserted-by":"crossref","first-page":"G51","DOI":"10.1152\/ajpgi.00110.2024","article-title":"Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis","volume":"328","author":"Nielsen","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2026.04.029_bib133","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1002\/2211-5463.13272","article-title":"Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways","volume":"11","author":"Suzuki-Kemuriyama","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jhep.2026.04.029_bib134","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell."},{"key":"10.1016\/j.jhep.2026.04.029_bib135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","article-title":"Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling","volume":"79","author":"Kotsiliti","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib136","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med."},{"key":"10.1016\/j.jhep.2026.04.029_bib137","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000508636","article-title":"Western Diet Promotes Renal Injury, Inflammation, and Fibrosis in a Murine Model of Alstr\u00f6m Syndrome","volume":"144","author":"Kim","year":"2020","journal-title":"Nephron."},{"key":"10.1016\/j.jhep.2026.04.029_bib138","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116371","article-title":"PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways","volume":"44","author":"Sherman","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib141","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jhep.2024.10.048","article-title":"PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis","volume":"82","author":"Wang","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib142","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib143","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2024.01.032","article-title":"Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models","volume":"80","author":"Caon","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib144","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.cgh.2023.04.024","article-title":"Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease","volume":"21","author":"Rosso","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib146","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib147","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.04.029_bib148","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib149","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"Holmen","year":"2014","journal-title":"Nat Genet."},{"key":"10.1016\/j.jhep.2026.04.029_bib151","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","volume":"70","author":"Thangapandi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib152","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib153","article-title":"Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis","volume":"8","author":"Das","year":"2026","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib154","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.kint.2023.12.009","article-title":"Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH)","volume":"105","author":"Li","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.jhep.2026.04.029_bib155","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1038\/s41467-024-50660-y","article-title":"A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma","volume":"15","author":"Jeong","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib156","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib157","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gutjnl-2025-336127","article-title":"Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts","volume":"75","author":"Huo","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib158","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib159","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100319","article-title":"Metabolic dysfunction and alcohol-associated liver disease (MetALD)","volume":"3","author":"Gao","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib160","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/acer.14700","article-title":"A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice","volume":"45","author":"Schonfeld","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2026.04.029_bib161","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1698","article-title":"An Experimental DUAL Model of Advanced Liver Damage","volume":"5","author":"Bened\u00e9-Ubieto","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib162","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2015.4","article-title":"Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity","volume":"5","author":"Duly","year":"2015","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.jhep.2026.04.029_bib164","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcmgh.2018.01.003","article-title":"Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis","volume":"5","author":"Zhou","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib165","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000450","article-title":"A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis","volume":"8","author":"Babuta","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib166","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00394-015-0929-7","article-title":"Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob\/ob mice","volume":"55","author":"Kanuri","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jhep.2026.04.029_bib167","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1538\/expanim.22-0160","article-title":"New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease","volume":"72","author":"Cheng","year":"2023","journal-title":"Exp Anim"},{"key":"10.1016\/j.jhep.2026.04.029_bib168","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.alcohol.2012.08.004","article-title":"Rodent models of alcoholic liver disease: of mice and men","volume":"46","author":"Brandon-Warner","year":"2012","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2026.04.029_bib169","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.1840100417","article-title":"Experimental methods of ethanol administration","volume":"10","author":"Lieber","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib170","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2015.11.005","article-title":"Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease","volume":"64","author":"Nevzorova","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib171","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1530-0277.2011.01720.x","article-title":"Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation","volume":"36","author":"Roychowdhury","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2026.04.029_bib172","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.532","article-title":"Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice","volume":"8","author":"Hao","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2026.04.029_bib173","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2026.04.029_bib174","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41598-017-02887-7","article-title":"Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances","volume":"7","author":"Yan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0270-9139(91)90246-R","article-title":"Hepatic fibrosis and cirrhosis after chronic administration of alcohol and \"low-dose\u201d carbon tetrachloride vapor in the rat","volume":"13","author":"Hall","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib176","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.1840050212","article-title":"Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet","volume":"5","author":"Tsukamoto","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib177","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nprot.2012.014","article-title":"Mouse intragastric infusion (iG) model","volume":"7","author":"Ueno","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2026.04.029_bib178","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib179","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA no longer has to require animal testing for new drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science."},{"key":"10.1016\/j.jhep.2026.04.029_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103496","article-title":"The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory table","volume":"28","author":"Stewart","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jhep.2026.04.029_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312615","article-title":"Induction of MASH in three-dimensional bioprinted human liver tissue","volume":"19","author":"Joshi","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib182","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib183","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications","volume":"25","author":"Ramos","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jhep.2026.04.029_bib185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ajpath.2023.12.005","article-title":"Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis","volume":"194","author":"Tan","year":"2024","journal-title":"Am J Pathol."},{"key":"10.1016\/j.jhep.2026.04.029_bib186","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41423-025-01312-8","article-title":"Human liver immunology: from in vitro models to new insights","volume":"22","author":"Rezvani","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2026.04.029_bib187","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jcmgh.2023.01.014","article-title":"Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations","volume":"15","author":"Rezvani","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib188","article-title":"Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models","volume":"41","author":"Green","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.jhep.2026.04.029_bib189","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010036","article-title":"In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal","volume":"10","author":"Soret","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4396403","article-title":"Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene\/Ethanol CoExposure","volume":"2018","author":"Bucher","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jhep.2026.04.029_bib191","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","article-title":"Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD","volume":"57","author":"Donne","year":"2022","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib192","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41592-021-01198-0","article-title":"SpaceM reveals metabolic states of single cells","volume":"18","author":"Rappez","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhep.2026.04.029_bib193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/13813455.2012.683442","article-title":"The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism","volume":"118","author":"Samanez","year":"2012","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.jhep.2026.04.029_bib194","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","article-title":"Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity","volume":"37","author":"Allard","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jhep.2026.04.029_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","article-title":"Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis","volume":"302","author":"Tolosa","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2026.04.029_bib196","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.mcb.2016.04.006","article-title":"Incomplete cytokinesis\/binucleation in mammals: The powerful system of hepatocytes","volume":"137","author":"Fortier","year":"2017","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.jhep.2026.04.029_bib197","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s42255-019-0124-x","article-title":"Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity","volume":"1","author":"Seitz","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib198","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cmet.2022.09.022","article-title":"Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes","volume":"34","author":"Sekar","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib199","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2024.06.040","article-title":"Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kwon","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121006","article-title":"A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model","volume":"276","author":"Kumar","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jhep.2026.04.029_bib201","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad5766","article-title":"Human iPSC-derived liver co-culture spheroids to model liver fibrosis","volume":"16","author":"Cools","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.jhep.2026.04.029_bib202","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41467-025-56024-4","article-title":"Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis","volume":"16","author":"Mart\u00ednez Garc\u00eda de la Torre","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib203","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/hep.32063","article-title":"Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells","volume":"74","author":"Tilson","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib204","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/HEP.0000000000000669","article-title":"Alternatives to animal testing to assess MASH drugs and hepatotoxicity","volume":"81","author":"Brenner","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117544","article-title":"3D culture models to study pathophysiology of steatotic liver disease","volume":"393","author":"Caddeo","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2026.04.029_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143723","article-title":"NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models","volume":"15","author":"Fang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2026.04.029_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103111","article-title":"Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress","volume":"5","author":"Kim","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jhep.2026.04.029_bib208","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","article-title":"Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease","volume":"159","author":"Ramli","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib209","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/15376516.2020.1800881","article-title":"Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing","volume":"30","author":"Basu","year":"2020","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.jhep.2026.04.029_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102391","article-title":"Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers","volume":"4","author":"Liu","year":"2023","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jhep.2026.04.029_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071629","article-title":"Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.jhep.2026.04.029_bib212","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/ten.tec.2018.0134","article-title":"Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells","volume":"24","author":"Baze","year":"2018","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.jhep.2026.04.029_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040964","article-title":"Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis","volume":"9","author":"Hurrell","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2026.04.029_bib214","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000374","article-title":"The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model","volume":"8","author":"van Riet","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2026.04.029_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32722-6","article-title":"Human hepatic 3D spheroids as a model for steatosis and insulin resistance","volume":"8","author":"Kozyra","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib217","first-page":"1531","article-title":"Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype","volume":"11","author":"Mukherjee","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhep.2026.04.029_bib218","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872312809666150119104806","article-title":"Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays","volume":"9","author":"Murayama","year":"2015","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.jhep.2026.04.029_bib219","doi-asserted-by":"crossref","DOI":"10.3791\/62868","article-title":"A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma","author":"Zaki","year":"2021","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jhep.2026.04.029_bib220","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s42255-022-00620-x","article-title":"BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD\/NASH","volume":"4","author":"Baboota","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib221","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acsptsci.0c00170","article-title":"Cytotoxicity, Retention, and Anti-inflammatory Effects of a CeO(2) Nanoparticle-Based Supramolecular Complex in a 3D Liver Cell Culture Model","volume":"4","author":"Eilenberger","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.04.029_bib222","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bcpt.13587","article-title":"3D human liver spheroids for translational pharmacology and toxicology","volume":"130","author":"Ingelman-Sundberg","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2026.04.029_bib223","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01951-7","article-title":"A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Str\u00f6bel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib224","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47737-w","article-title":"The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids","volume":"9","author":"Prill","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib225","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102247","article-title":"Discovery and Targeting of the Signaling Controls of PNPLA3 to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD\/NASH Settings","volume":"9","author":"Schwartz","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2026.04.029_bib226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2020-320646","article-title":"LPIAT1\/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover","volume":"70","author":"Tanaka","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.029_bib227","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","article-title":"Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kim","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib228","article-title":"DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids","volume":"7","author":"Yamamoto","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2020.06.030","article-title":"Alcohol-induced CYP2E1, mitochondrial dynamics and retrograde signaling in human hepatic 3D organoids","volume":"159","author":"Angireddy","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/7651_2024_595","article-title":"3D Cell Culture Models as a Platform for Studying Tumor Progression, Testing Treatment Responses, and Discovering Biomarkers","volume":"2951","author":"Korhan","year":"2025","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.jhep.2026.04.029_bib231","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221827","article-title":"Ex Vivo Tools and Models in MASLD Research","volume":"13","author":"Velliou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2026.04.029_bib232","article-title":"Modeling Immune Lineage Co-Development in Human Pluripotent Stem Cell-derived Liver Organoids","author":"Rezvani","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib233","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2026.04.029_bib234","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2023113898","article-title":"Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease","volume":"42","author":"Hess","year":"2023","journal-title":"Embo j."},{"key":"10.1016\/j.jhep.2026.04.029_bib235","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib236","article-title":"iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery","volume":"9","author":"Gurevich","year":"2020","journal-title":"Biol Open"},{"key":"10.1016\/j.jhep.2026.04.029_bib237","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hep.31857","article-title":"Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH","volume":"74","author":"McCarron","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib238","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41591-019-0660-7","article-title":"Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression","volume":"25","author":"Segovia-Miranda","year":"2019","journal-title":"Nat Med."},{"key":"10.1016\/j.jhep.2026.04.029_bib239","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cmet.2019.06.017","article-title":"Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism","volume":"30","author":"Collin de l'Hortet","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.jhep.2026.04.029_bib240","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib241","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1053\/j.gastro.2021.02.050","article-title":"Induced Pluripotent Stem Cell-derived Hepatocytes From Patients With Nonalcoholic Fatty Liver Disease Display a Disease-specific Gene Expression Profile","volume":"160","author":"Duwaerts","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.029_bib242","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","article-title":"En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib243","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2024.08.009","article-title":"ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD\/MASH","volume":"82","author":"Liu","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib244","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","article-title":"Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.jhep.2026.04.029_bib245","article-title":"Modeling alcohol-associated liver disease in humans using adipose stromal or stem cell-derived organoids","volume":"4","author":"Bi","year":"2024","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.jhep.2026.04.029_bib246","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s42003-021-02910-8","article-title":"Towards organoid culture without Matrigel","volume":"4","author":"Kozlowski","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib247","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2025.07.014","article-title":"Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease","volume":"84","author":"Ari\u00f1o","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib248","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2025.02.039","article-title":"Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis","volume":"83","author":"de Zawadzki","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib249","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41598-017-05134-1","article-title":"Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization","volume":"7","author":"Mazza","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib250","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302943","article-title":"Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC-Hepatocyte Culture","volume":"13","author":"Acun","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jhep.2026.04.029_bib251","doi-asserted-by":"crossref","DOI":"10.1038\/srep13079","article-title":"Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation","volume":"5","author":"Mazza","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib252","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s41232-022-00248-0","article-title":"State-of-the-art liver disease research using liver-on-a-chip","volume":"42","author":"Deguchi","year":"2022","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.jhep.2026.04.029_bib253","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2026.04.029_bib254","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib255","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tibtech.2020.11.014","article-title":"Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication","volume":"39","author":"Picollet-D'hahan","year":"2021","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jhep.2026.04.029_bib256","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/liv.14942","article-title":"Experimental liver models: From cell culture techniques to microfluidic organs-on-chip","volume":"41","author":"Polidoro","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.029_bib257","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2022.09.010","article-title":"Strategic use of organoids and organs-on-chip as biomimetic tools","volume":"144","author":"Santos","year":"2023","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib258","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcmgh.2017.11.012","article-title":"Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies","volume":"5","author":"Underhill","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib259","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1177\/1535370217707731","article-title":"Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems","volume":"242","author":"Soto-Gutierrez","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jhep.2026.04.029_bib260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159729","article-title":"Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device","volume":"11","author":"Gori","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib261","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hep.31106","article-title":"Liver-on-a-Chip Models of Fatty Liver Disease","volume":"71","author":"Hassan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib262","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep4.1450","article-title":"A Microphysiological System for Studying Nonalcoholic Steatohepatitis","volume":"4","author":"Kostrzewski","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib263","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep4.1647","article-title":"Human Nonalcoholic Steatohepatitis on a Chip","volume":"5","author":"Freag","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib264","article-title":"Dissecting Acute Drug-Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver-On-A-Chip Model","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhep.2026.04.029_bib265","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s42255-020-0214-9","article-title":"Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis","volume":"2","author":"Vacca","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2026.04.029_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120904","article-title":"A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids","volume":"275","author":"Teng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jhep.2026.04.029_bib267","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92264-2","article-title":"Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation","volume":"11","author":"Slaughter","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.jhep.2026.04.029_bib268","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","article-title":"Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease","volume":"6","author":"Yang","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jhep.2026.04.029_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109393","article-title":"Modeling alcohol-associated liver disease in a human Liver-Chip","volume":"36","author":"Nawroth","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib270","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"de Graaf","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2026.04.029_bib271","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137137","article-title":"Best Practices and Progress in Precision-Cut Liver Slice Cultures","volume":"22","author":"Dewyse","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.jhep.2026.04.029_bib272","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2013.01.009","article-title":"Precision-cut liver slices: a tool to model the liver ex vivo","volume":"58","author":"Olinga","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib273","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12072-018-9913-7","article-title":"Precision-cut liver slices: a versatile tool to advance liver research","volume":"13","author":"Palma","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2026.04.029_bib274","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3748\/wjg.v23.i2.204","article-title":"Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease","volume":"23","author":"Kostrzewski","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.04.029_bib275","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.30651","article-title":"A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices","volume":"70","author":"Paish","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib276","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2018.01.012","article-title":"Precision-cut human liver slice cultures as an immunological platform","volume":"455","author":"Wu","year":"2018","journal-title":"J Immunol Methods."},{"key":"10.1016\/j.jhep.2026.04.029_bib277","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2026.04.029_bib278","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41597-023-02220-0","article-title":"Transcriptomic profiling of induced steatosis in human and mouse precision-cut liver slices","volume":"10","author":"Simon","year":"2023","journal-title":"Sci Data"},{"key":"10.1016\/j.jhep.2026.04.029_bib279","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874467208666150817112345","article-title":"Review: Precision Cut Liver Slices for the Evaluation of Fatty Liver and Fibrosis","volume":"10","author":"Thiele","year":"2017","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.jhep.2026.04.029_bib280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/toxsci\/kfs337","article-title":"An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells","volume":"132","author":"Karim","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2026.04.029_bib281","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010150","article-title":"Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease","volume":"25","author":"Rastovic","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.jhep.2026.04.029_bib282","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcp.2008.05.012","article-title":"An in vitro method of alcoholic liver injury using precision-cut liver slices from rats","volume":"76","author":"Klassen","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2026.04.029_bib283","article-title":"A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Hammoutene","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib284","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","article-title":"MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming","volume":"14","author":"Mabire","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib285","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2016.01.016","article-title":"Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid","volume":"64","author":"Ijssennagger","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib286","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12864-015-1969-3","article-title":"The impact of PPAR\u03b1 activation on whole genome gene expression in human precision cut liver slices","volume":"16","author":"Janssen","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jhep.2026.04.029_bib287","article-title":"Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis","volume":"13","author":"Aoudjehane","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhep.2026.04.029_bib288","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99008-2","article-title":"Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis","volume":"11","author":"Bhattacharya","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib289","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.30890","article-title":"Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease","volume":"71","author":"De Chiara","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib290","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/hep.32048","article-title":"A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis","volume":"74","author":"Garcia-Macia","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156237","article-title":"Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver","volume":"168","author":"Gruevska","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2026.04.029_bib292","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4254\/wjh.v12.i11.931","article-title":"Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo","volume":"12","author":"Shepherd","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib293","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0021-9673(01)97311-X","article-title":"Chiral recognition model for the resolution of ephedrine and related alpha,beta-aminoalcohols as enantiomeric oxazolidine derivatives","volume":"355","author":"Wainer","year":"1986","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jhep.2026.04.029_bib294","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tiv.2016.05.012","article-title":"Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis","volume":"35","author":"Westra","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jhep.2026.04.029_bib295","article-title":"Improved Precision-Cut Liver Slice Cultures for Testing Drug-Induced Liver Fibrosis","volume":"9","author":"Dewyse","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2026.04.029_bib296","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib297","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib298","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.cell.2023.07.017","article-title":"Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions","volume":"186","author":"Kaffe","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.04.029_bib299","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111647","article-title":"Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers","volume":"9","author":"Kisoh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhep.2026.04.029_bib300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142145","article-title":"Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA\/SCID Mice","volume":"10","author":"Tateno","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.029_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101165","article-title":"Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers","volume":"31","author":"Wang","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jhep.2026.04.029_bib302","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2008.10.020","article-title":"The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model","volume":"50","author":"Butura","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib303","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.freeradbiomed.2010.07.026","article-title":"Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice","volume":"49","author":"Lu","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2026.04.029_bib304","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/jhep.2002.33720","article-title":"Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage","volume":"36","author":"Morgan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib305","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep4.1115","article-title":"The role of human cytochrome P450 2E1 in liver inflammation and fibrosis","volume":"1","author":"Xu","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib306","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep4.1446","article-title":"Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery","volume":"4","author":"Allen","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.029_bib307","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jhep.2026.04.029_bib308","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal","volume":"29","author":"Weng","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhep.2026.04.029_bib309","article-title":"Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Schwabe","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib310","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2026.04.029_bib311","article-title":"Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials","author":"Lackner","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib312","series-title":"MacSween's Pathology of the Liver","first-page":"330","article-title":"Chapter 5 - Fatty Liver Disease","author":"Tiniakos","year":"2024"},{"key":"10.1016\/j.jhep.2026.04.029_bib313","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib314","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.029_bib315","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2021.05.029","article-title":"Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease","volume":"75","author":"Lackner","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.029_bib316","article-title":"The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD","volume":"8","author":"Tiniakos","year":"2026","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib317","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0035-1562942","article-title":"Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification","volume":"35","author":"Burt","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2026.04.029_bib318","doi-asserted-by":"crossref","first-page":"230s","DOI":"10.1097\/01.alc.0000191948.27106.85","article-title":"Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD)","volume":"29","author":"Nakano","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2026.04.029_bib319","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73739-4","article-title":"Characterizing alcohol-related and metabolic dysfunction-associated steatotic liver disease cirrhosis via fibrotic pattern analysis","volume":"14","author":"Fukushima","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.029_bib320","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030507","article-title":"A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices","volume":"11","author":"Prins","year":"2019","journal-title":"Nutrients"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:56:57Z","timestamp":1794477417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":320,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0168827826002631"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL position paper on preclinical models of steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}